Related Experiment Video

Updated: Aug 12, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Current challenges in Wilms' tumor management

Lyndon M Gommersall1, Manit Arya, Imran Mushtaq

  • 1Great Ormond Street Hospital, London, UK.

Nature Clinical Practice. Oncology
|November 3, 2005
PubMed

Insights

Wilms tumor, a childhood kidney cancer, now has an 85% survival rate due to successful clinical trials. Treatment is optimized by stratifying patients based on tumor stage and histology, reducing morbidity.

Area of Science:

  • Pediatric Oncology
  • Nephrology
  • Cancer Research

Background:

  • Wilms tumor is a common pediatric renal cancer affecting children under two.
  • Recent clinical trials have improved survival rates to 85% and reduced treatment-related morbidity.
  • Less-intensive chemotherapy regimens are now available for patients with favorable prognostic factors.

Purpose of the Study:

  • To discuss current management strategies for Wilms tumor.
  • To highlight advances in treating this childhood kidney cancer.
  • To explore the role of prognostic factors in optimizing treatment.

Main Methods:

  • Review of established and salvage chemotherapy regimens.
  • Discussion of treatment stratification based on tumor stage and histology.
  • Analysis of treatment-related morbidity and survival outcomes.

Main Results:

  • Overall survival for Wilms tumor patients has reached 85%.
  • Treatment-related morbidity has been significantly reduced.
  • Stratification by stage and histology allows for optimized, less-aggressive chemotherapy.

Conclusions:

  • Wilms tumor management has advanced significantly, improving survival and reducing morbidity.
  • Patient stratification based on prognostic factors is key to optimizing treatment.
  • Further research is needed to refine current regimens and identify new prognostic factors.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...